Trial · NCT01106625
Adverse event totals18
The totals the trial posted for each group.
1 to 18 of 18
Download this page as JSON| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | Placebo: Baseline to Week 26 | ||
| Total, all-cause mortality | Canagliflozin 100 mg: Baseline to Week 26 | ||
| Total, all-cause mortality | Canagliflozin 300 mg: Baseline to Week 26 | ||
| Total, all-cause mortality | Placebo: Baseline to Week 52 | ||
| Total, all-cause mortality | Canagliflozin 100 mg: Baseline to Week 52 | ||
| Total, all-cause mortality | Canagliflozin 300 mg: Baseline to Week 52 | ||
| Total, other adverse events | Placebo: Baseline to Week 26 | 31 | 156 |
| Total, other adverse events | Canagliflozin 100 mg: Baseline to Week 26 | 42 | 157 |
| Total, other adverse events | Canagliflozin 300 mg: Baseline to Week 26 | 38 | 156 |
| Total, other adverse events | Placebo: Baseline to Week 52 | 52 | 156 |
| Total, other adverse events | Canagliflozin 100 mg: Baseline to Week 52 | 63 | 157 |
| Total, other adverse events | Canagliflozin 300 mg: Baseline to Week 52 | 54 | 156 |
| Total, serious adverse events | Placebo: Baseline to Week 26 | 9 | 156 |
| Total, serious adverse events | Canagliflozin 100 mg: Baseline to Week 26 | 5 | 157 |
| Total, serious adverse events | Canagliflozin 300 mg: Baseline to Week 26 | 6 | 156 |
| Total, serious adverse events | Placebo: Baseline to Week 52 | 13 | 156 |
| Total, serious adverse events | Canagliflozin 100 mg: Baseline to Week 52 | 7 | 157 |
| Total, serious adverse events | Canagliflozin 300 mg: Baseline to Week 52 | 8 | 156 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01106625/event-totals